KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to -$152.6 million.

  • Charles River Laboratories International's Cash from Financing Activities rose 2646.29% to -$152.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$560.7 million, marking a year-over-year decrease of 5953.71%. This contributed to the annual value of -$550.9 million for FY2024, which is 54420.08% down from last year.
  • According to the latest figures from Q3 2025, Charles River Laboratories International's Cash from Financing Activities is -$152.6 million, which was up 2646.29% from -$226.9 million recorded in Q2 2025.
  • Charles River Laboratories International's Cash from Financing Activities' 5-year high stood at $518.0 million during Q2 2021, with a 5-year trough of -$285.9 million in Q2 2024.
  • Moreover, its 5-year median value for Cash from Financing Activities was -$71.5 million (2023), whereas its average is -$25.8 million.
  • Per our database at Business Quant, Charles River Laboratories International's Cash from Financing Activities soared by 59757.44% in 2021 and then plummeted by 67410.33% in 2025.
  • Charles River Laboratories International's Cash from Financing Activities (Quarter) stood at -$219.0 million in 2021, then dropped by 13.69% to -$249.0 million in 2022, then skyrocketed by 149.63% to $123.6 million in 2023, then crashed by 161.41% to -$75.9 million in 2024, then plummeted by 101.13% to -$152.6 million in 2025.
  • Its Cash from Financing Activities was -$152.6 million in Q3 2025, compared to -$226.9 million in Q2 2025 and -$105.3 million in Q1 2025.